Neoadjuvant chemotherapy for primary operable breast cancer: A quality assessment of the NACT-regime
This study aimed to investigate the efficacy of the 2016 guidelines for primary operable breast cancer, initiating with six cycles of neoadjuvant chemotherapy prior to surgery. Findings indicate that this regime is a favourable treatment strategy, as a majority underwent lumpectomies and were spared of axillary dissection
Brænder du for at skrive?
Vil du gerne dele din forskning eller dine kliniske erfaringer med dine kollegaer inden for netop dit speciale? Har du en ide til en artikel, som du gerne vil udgive hos os? Send redaktionen en mail på redaktion@bpno.dk
Send mail til redaktionen